At #ASCO24, our #oncology team will be onsite showcasing our expanding solid tumor research and commitment to transforming cancer care. Stop by booth 23093 to learn more.
Tentang kami
AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.
- Website
-
http://www.abbvie.com
Link eksternal untuk AbbVie
- Industri
- Manufaktur Farmasi
- Ukuran perusahaan
- 10.001+ karyawan
- Kantor Pusat
- North Chicago, Illinois
- Jenis
- Perusahaan Publik
- Spesialisasi
- Biopharmaceutical, Biotechnology, Innovation, Research and Development, Manufacturing, Biotherapeutics, Oncology, Immunology, Virology, Neuroscience, Womens Health, Aesthetics, Eye Care
Lokasi
Karyawan di AbbVie
Update
-
NEWS: The European Medicines Agency's #CHMP granted a positive opinion for our investigational treatment in #UlcerativeColitis. Read more: https://bit.ly/4bDSiUJ #IBD [Video description: On-screen text reads, “Immunology News. Positive CHMP Opinion in Ulcerative Colitis.”]
-
Attending #ASCO24? Meet with our team of experts working to transform the standards of care for #cancer patients. Explore our career opportunities in #oncology: https://bit.ly/4bZsAtG
-
Over the past decade, new approaches and innovation have enabled scientists to reimagine #BloodCancer research – but there's more to discover. See why our scientists won’t settle when it comes to treating #cancer. https://bit.ly/3V2ggSv #WorldBloodCancerDay
-
JUST IN: We’re presenting three oral abstracts at #ASCO24 highlighting new data from our #ADC platform in #SolidTumors with high unmet needs. Read more: https://bit.ly/4bS231q [Video description: On-screen text reads, “Oncology News.”]
-
Landos Biopharma, Inc. is now part of AbbVie. This #acquisition expands our #IBD pipeline and advances our commitment to make a real difference in people’s lives. Learn more: https://bit.ly/3RlEFSn $ABBV [Video description: On-screen text reads, “Landos is now part of AbbVie" followed by the AbbVie and Landos logos.]
-
Supriya Nair, global co-chair of our Asian Leadership Network employee resource group, shares how our culture inspires her to be her most authentic self. See the difference you can make – join us: https://lnkd.in/e_RW34f7 #AAPIHM #AbbVieLife [Image description: Supriya Nair, Associate Director, Field Tools, AbbVie, says “AbbVie encourages me to be myself by fostering an environment of belonging and psychological safety, empowering me to make a positive impact through innovation, inclusiveness and authenticity.”]
-
Today marks the start of our summer #intern program. As we welcome this year’s group, hear some of our development program members’ advice for our 250+ incoming students, representing 92 universities from 30 states, supporting teams in R&D, commercial, operations and more. #AbbVieLife [Video description: Five AbbVie development program members answer the question, “What advice would you give our 2024 summer interns?”]
-
To truly understand how medications will work for people of different races, ethnicities, genders and backgrounds, #ClinicalTrials need greater diversity. Explore the bold actions we’re taking to drive greater inclusion and engage patients, caregivers and physicians in the process: https://bit.ly/4bG4u72 #ClinicalTrialsDay
-
On #ClinicalTrialsDay, we’re grateful for the researchers, investigators and patients who make our #ClinicalTrials possible. Thank you for supporting our efforts to discover future treatments and cures. Learn more: https://bit.ly/4bLYM3O [Video description: On-screen text reads, “33K+ Clinical Trial Participants; 147 Active Clinical Trial Studies; 6 Therapeutic Areas; One Big Thank You.”]
Halaman afiliasi
Halaman serupa
Stok
ABBV
NYSE
Penundaan 20 menit
USD161,24
4,93 (3,154%)
- Buka
- 156,65
- Rendah
- 156,2
- Tinggi
- 161,64
Data dari Refinitiv
Lihat selengkapnya mengenaiPendanaan
Putaran Terakhir
Hutang pasca IPOUSD15.000.000.000,00